 NEW YORK and VIENNA, Austria, Sept. 07, 2021 GLOBE NEWSWIRE -- HOOKIPA Pharma Inc. NASDAQ: HOOK, HOOKIPA, a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPAs management team will participate and present at the following upcoming virtual investor conferences: 